Articoli correlati a Genetic pathogenesis and targeted therapy in Chronic...
Genetic pathogenesis and targeted therapy in Chronic Myeloid Leukemia: Missing lessons and current challenges in diagnosis, prognosis and treatment of CML in post-imatinib cancer therapy era - Brossura
- EditoreLAP LAMBERT Academic Publishing
- Data di pubblicazione2020
- ISBN 10 6202679956
- ISBN 13 9786202679954
- RilegaturaCopertina flessibile
- Numero di pagine72
Compra nuovo
Scopri di più su questo articolo
EUR 39,90
Spese di spedizione:
EUR 23,00
Da: Germania a: U.S.A.
I migliori risultati di ricerca su AbeBooks
Foto dell'editore
Genetic pathogenesis and targeted therapy in Chronic Myeloid Leukemia
Editore:
LAP LAMBERT Academic Publishing Jul 2020
(2020)
ISBN 10: 6202679956
ISBN 13: 9786202679954
Nuovo
Taschenbuch
Quantità: 2
Da:
Valutazione libreria
Descrizione libro Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to 'almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research. 72 pp. Englisch. Codice articolo 9786202679954
Compra nuovo
EUR 39,90
Convertire valuta
Foto dell'editore
Genetic pathogenesis and targeted therapy in Chronic Myeloid Leukemia : Missing lessons and current challenges in diagnosis, prognosis and treatment of CML in post-imatinib cancer therapy era
Editore:
LAP LAMBERT Academic Publishing
(2020)
ISBN 10: 6202679956
ISBN 13: 9786202679954
Nuovo
Taschenbuch
Quantità: 1
Da:
Valutazione libreria
Descrizione libro Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - 21st century innovations in cutting-edge technologies have led to discovery of novel genetic, immunological and cell biological mechanisms underlying biology and parthenogenesis of different diseases including cancer. A special revolution has been made by this in diagnosis, prognosis and treatment of hematological malignancies specifically leukemias and lymphomas. Many molecular and immunological biomarkers have been discovered and utilized as drug targets to develop targeted molecular therapies in this regard. These efforts have specifically revolutionized clinically management of Chronic Myeloid Leukemia which has been transformed from a fatal disease to 'almost-cured' cancer in first quarter of 21st century. Nevertheless, due to devil dynamic nature of cancer as a disease, there are still many challenges in CML prognosis and treatment. This book provides an account of molecular pathogenesis as well as current and prospective targeted therapies in CML. It also highlights some missing lessons and challenges in diagnosis, prognostic stratification, treatment monitoring, drug resistance and treatment-free remission of CML as well as major focus areas in CML treatment and research. Codice articolo 9786202679954
Compra nuovo
EUR 40,38
Convertire valuta
Immagini fornite dal venditore
Genetic pathogenesis and targeted therapy in Chronic Myeloid Leukemia
Editore:
LAP LAMBERT Academic Publishing
(2020)
ISBN 10: 6202679956
ISBN 13: 9786202679954
Nuovo
Brossura
Quantità: > 20
Da:
Valutazione libreria
Descrizione libro Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Iqbal ZafarDr Zafar Iqbal obtained his PhD in molecular pathogenesis and pharmacogenomics of hematological malignancies and postdoctoral fellowship in pre-clinical drug testing of leukemia. He has published his research in various IS. Codice articolo 494631254
Compra nuovo
EUR 34,25
Convertire valuta